119 related articles for article (PubMed ID: 36842376)
1. Generation of induced pluripotent stem cell line carrying frameshift variants in NPHP1 (UCSFi001-A-68) using CRISPR/Cas9.
Dyke E; Bijnagte-Schoenmaker C; Wu KM; Oudakker A; Roepman R; Nadif Kasri N
Stem Cell Res; 2023 Apr; 68():103053. PubMed ID: 36842376
[TBL] [Abstract][Full Text] [Related]
2. Generation of induced pluripotent stem cell lines carrying monoallelic (UCSFi001-A-60) or biallelic (UCSFi001-A-61; UCSFi001-A-62) frameshift variants in CACNA1A using CRISPR/Cas9.
Hommersom MP; Bijnagte-Schoenmaker C; Albert S; van de Warrenburg BPC; Nadif Kasri N; van Bokhoven H
Stem Cell Res; 2022 May; 61():102730. PubMed ID: 35286975
[TBL] [Abstract][Full Text] [Related]
3. Generation of NPHP1 knockout human pluripotent stem cells by a practical biallelic gene deletion strategy using CRISPR/Cas9 and ssODN.
Nakano Y; Susa K; Yanagi T; Hiraoka Y; Suzuki T; Mori T; Ando F; Mandai S; Fujiki T; Rai T; Uchida S; Sohara E
In Vitro Cell Dev Biol Anim; 2022 Feb; 58(2):85-95. PubMed ID: 35165826
[TBL] [Abstract][Full Text] [Related]
4. Generation of CRISPR-Cas9 edited human induced pluripotent stem cell line carrying BAG3 V468M mutation in its BAG domain.
Duboscq-Bidot L; Hoareau B; Ader F; Fontaine V; Villard E
Stem Cell Res; 2024 Feb; 74():103294. PubMed ID: 38183888
[TBL] [Abstract][Full Text] [Related]
5. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
[TBL] [Abstract][Full Text] [Related]
6. Defective INPP5E distribution in NPHP1-related Senior-Loken syndrome.
Ning K; Song E; Sendayen BE; Prosseda PP; Chang KC; Ghaffarieh A; Alvarado JA; Wang B; Haider KM; Berbari NF; Hu Y; Sun Y
Mol Genet Genomic Med; 2021 Jan; 9(1):e1566. PubMed ID: 33306870
[TBL] [Abstract][Full Text] [Related]
7. Differential requirement of NPHP1 for compartmentalized protein localization during photoreceptor outer segment development and maintenance.
Datta P; Cribbs JT; Seo S
PLoS One; 2021; 16(5):e0246358. PubMed ID: 33961633
[TBL] [Abstract][Full Text] [Related]
8. Generation of an induced pluripotent stem cell line carrying biallelic deletions (SCTCi019-B) in ALDH7A1 using CRISPR/Cas9.
Schuurmans IME; Wu KM; van Karnebeek CDM; Nadif Kasri N; Garanto A
Stem Cell Res; 2023 Sep; 71():103173. PubMed ID: 37540965
[TBL] [Abstract][Full Text] [Related]
9. The centrosomal kinase Plk1 localizes to the transition zone of primary cilia and induces phosphorylation of nephrocystin-1.
Seeger-Nukpezah T; Liebau MC; Höpker K; Lamkemeyer T; Benzing T; Golemis EA; Schermer B
PLoS One; 2012; 7(6):e38838. PubMed ID: 22701722
[TBL] [Abstract][Full Text] [Related]
10. Generation of a heterozygous SCN5A knockout human induced pluripotent stem cell line by CRISPR/Cas9 edition.
Gizon M; Duboscq-Bidot L; El Kassar L; Bobin P; Ader F; Giraud-Triboult K; Charron P; Villard E; Fontaine V; Neyroud N
Stem Cell Res; 2022 Apr; 60():102680. PubMed ID: 35093717
[TBL] [Abstract][Full Text] [Related]
11. Generation of gene corrected human isogenic iPSC lines (IDVi003-A_CR13, IDVi003-A_CR21, IDVi003-A_CR24) from an inherited retinal dystrophy patient-derived IPSC line ITM2B-5286-3 (IDVi003-A) carrying the ITM2B c.782A > C variant using CRISPR/Cas9.
Ben Yacoub T; Letellier C; Wohlschlegel J; Condroyer C; Slembrouck-Brec A; Goureau O; Zeitz C; Audo I
Stem Cell Res; 2023 Sep; 71():103166. PubMed ID: 37473460
[TBL] [Abstract][Full Text] [Related]
12. Generation of an induced pluripotent stem cell line carrying a biallelic deletion (SCTCi019-A) in GCDH using CRISPR/Cas9.
Schuurmans IME; Wu KM; van Karnebeek CDM; Nadif Kasri N; Garanto A
Stem Cell Res; 2023 Jun; 69():103069. PubMed ID: 36947993
[TBL] [Abstract][Full Text] [Related]
13. Generation of two human induced pluripotent stem cell lines derived from two juvenile nephronophthisis patients with NPHP1 deletion.
Arai Y; Takami M; An Y; Matsuo-Takasaki M; Hemmi Y; Wakabayashi T; Inoue J; Noguchi M; Nakamura Y; Sugimoto K; Takemura T; Okita K; Osafune K; Takasato M; Hayata T; Hayashi Y
Stem Cell Res; 2020 May; 45():101815. PubMed ID: 32361464
[TBL] [Abstract][Full Text] [Related]
14. Generation of a homozygous RANGRF knockout hiPSC line by CRISPR/Cas9 system.
Jiang M; Tang C; Luo X; Zhou X; Chen M; Chi Y; Lai L; Zou Q
Stem Cell Res; 2023 Sep; 71():103136. PubMed ID: 37327621
[TBL] [Abstract][Full Text] [Related]
15. Efficient introduction of an isogenic homozygous mutation to induced pluripotent stem cells from a hereditary hearing loss family using CRISPR/Cas9 and single-stranded donor oligonucleotides.
Dong Y; Peng T; Wu W; Tan D; Liu X; Xie D
J Int Med Res; 2019 Apr; 47(4):1717-1730. PubMed ID: 30819013
[TBL] [Abstract][Full Text] [Related]
16. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
[TBL] [Abstract][Full Text] [Related]
17. Generation of corrected hiPSC clones from a Cornelia de Lange Syndrome (CdLS) patient through CRISPR-Cas-based technology.
Umbach A; Maule G; Kheir E; Cutarelli A; Foglia M; Guarrera L; Fava LL; Conti L; Garattini E; Terao M; Cereseto A
Stem Cell Res Ther; 2022 Sep; 13(1):440. PubMed ID: 36056433
[TBL] [Abstract][Full Text] [Related]
18. Generation of two induced pluripotent stem cell lines (TMOi001-A-5, TMOi001-A-6) carrying variants in DISC1 exon 2 using CRISPR/Cas9 gene editing.
Heider J; Sperlich D; Vogel S; Breitmeyer R; Volkmer H
Stem Cell Res; 2022 Oct; 64():102925. PubMed ID: 36154917
[TBL] [Abstract][Full Text] [Related]
19. Generation of two iPSC lines (MHHi001-A-12 and MHHi001-A-13) carrying biallelic truncating mutations at the 3'-end of SRCAP using CRISPR/Cas9.
Rhode J; Hagenau L; Beimdiek J; Ullmann R; Hossain F; Tzvetkova A; Jensen LR; Kuss AW
Stem Cell Res; 2023 Dec; 73():103249. PubMed ID: 38006676
[TBL] [Abstract][Full Text] [Related]
20. Efficient Gene Reframing Therapy for Recessive Dystrophic Epidermolysis Bullosa with CRISPR/Cas9.
Takashima S; Shinkuma S; Fujita Y; Nomura T; Ujiie H; Natsuga K; Iwata H; Nakamura H; Vorobyev A; Abe R; Shimizu H
J Invest Dermatol; 2019 Aug; 139(8):1711-1721.e4. PubMed ID: 30831133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
